We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
110 result(s) found, displaying 21 to 30
-
Prescription medicine registrationActive ingredients: terlipressin acetate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for PARECOXIB MYX parecoxib (as sodium) 40 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Dexamethasone SXP dexamethasone phosphate (as sodium) 4 mg/1 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Dexamethasone SXP dexamethasone phosphate (as sodium) 8 mg/2 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Dexamethasone ANS dexamethasone phosphate (as sodium) 4 mg/1 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Dexamethasone HMH dexamethasone phosphate (as sodium) 4 mg/1 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Dexamethasone HMH dexamethasone phosphate (as sodium) 8 mg/2 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Dexamethasone ANS dexamethasone phosphate (as sodium) 8 mg/2 mL injection solution ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIVALIRUDIN SXP bivalirudin (as trifluoroacetate) 250 mg powder for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIVALIRUDIN HMH bivalirudin (as trifluoroacetate) 250 mg powder for injection vial.